Hyperphosphatemia (i.e., serum phosphate >5.6mg/dL) is associated with a higher risk of mortality in a fully adjusted model.1 In the ASN Kidney Week 2022, Professor Michal L. Melamed from Albert Einstein College of Medicine, the United States (US), presented her group’s study on the hyperphosphatemi